Lonza invests in exosome category, acquires development and manufacturing capabilities 04-Nov-2021 By Jane Byrne Lonza has been investing in developing exosome manufacturing and characterization technologies for the past five years, and this week it ramped up its focus on that category by acquiring two sites.
Takeda taps Evox for exosome therapeutics 30-Mar-2020 By Ben Hargreaves The partners will focus on developing five potential exosome treatment for rare diseases.
Milk-derived drug delivery system given Roche backing 24-Jul-2018 By Ben Hargreaves Roche has teamed up with PureTech to take advantage of its milk-derived exosome platform to potentially create oral formulations of antisense drugs.
